Results 131 to 140 of about 336,084 (346)

Two Different Cell Populations Is an Important Clue for Diagnosis of Primary Cutaneous Adenoid Cystic Carcinoma: Immunohistochemical Study

Case Reports in Pathology, 2017
Primary cutaneous adenoid cystic carcinoma (PCACC) is a very rare malignancy. The differential diagnosis of PCACCs in pathology practice can be difficult and a group of primary and metastatic lesions, including adenoid basal cell carcinoma of the skin ...
Banu Ince Alkan, Onder Bozdogan, Müjde Karadeniz, Nazan Bozdoğan   +3 more
doaj   +1 more source

Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer

Frontiers in Medicine, 2018
Immunotherapy for skin malignancies has ushered in a new era for cancer treatments by demonstrating unprecedented durable responses in the setting of metastatic Melanoma.
Jennifer A. Bridge, James C. Lee, James C. Lee, Adil Daud, James W. Wells, Jeffrey A. Bluestone   +5 more
doaj   +1 more source

Primary Basal Cell Carcinoma Masquerading as Metastatic Basal Cell Carcinoma in the Left Axilla. [PDF]

Cureus, 2023
Haskell Hanisch B, Frohm ML, Poling T.
europepmc   +1 more source

EXAMINATION OF METASTATIC BASAL CELL CARCINOMA

The Kurume Medical Journal, 1974
Since we experienced an extremely rare case of metastatic basal cell carcinoma, the details of the case and literary considerations were described in this paper.
Toshi Kato, Yasushi Aiko, Tsuyoshi Yamagami, Sumio Araki   +3 more
openaire   +2 more sources

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

Patient-based strategy for systemic treatment of metastatic renal cell carcinoma [PDF]

, 2010
Hartmut Kirchner, Dirk Strumberg, Amit Bahl, Friedrich Overkamp   +3 more
openalex   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer [PDF]

, 2019
Loss of the tumor suppressor phosphatase and tensin homolog (PTEN) is commonly observed in triple negative breast cancer (TNBC), leading to activation of the phosphoinositide 3-kinase (PI3K) signaling to promote tumor cell growth and chemotherapy ...
Guo, Zhanfang, Li, Shunqiang, Ma, Cynthia X, Rajput, Sandeep   +3 more
core   +1 more source

Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma [PDF]

, 2011
Mikayel Mkrtichyan, Anahit Ghochikyan, Hayk Davtyan, Nina Movsesyan, Dmitry Loukinov, Victor V. Lobanenkov, David H. Cribbs, Amanda K. Laust, Edward L. Nelson, Michael G. Agadjanyan   +9 more
openalex   +1 more source